Note 10 - Share Capital
|3 Months Ended|
Mar. 31, 2021
|Notes to Financial Statements|
|Stockholders' Equity Note Disclosure [Text Block]||
The Company has authorized share capital of an unlimited number of common voting shares.
2020At-The-Market (“ATM”) Facility
May 5, 2020,the Company entered into an equity distribution agreement with Piper Sandler and Canaccord Genuity acting as co-agents in connection with the
2020ATM Facility. Under the terms of the
2020ATM Facility, the Company
may,from time to time, sell Common Shares having an aggregate offering value of up to
$75million through Piper Sandler and Canaccord Genuity on the Nasdaq Capital Market. During the year ended
December 31, 2020and in the
March 21, 2021,the Company did
issue any shares under the
Loss per common share is calculated using the weighted average number of common shares outstanding and is presented in the table below:
The effect of any potential exercise of the Company's stock options outstanding during the
threemonth periods ended
March 31, 2021and
March 31, 2020has been excluded from the calculation of diluted loss per common share as it would be anti-dilutive.
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef